Bain Capital Specialty Finance Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bain Capital Specialty Finance in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Bain Capital Specialty Finance stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BCSF, but not buy additional shares or sell existing shares.
View analyst ratings for Bain Capital Specialty Finance or view top-rated stocks.

Wall Street analysts have given Bain Capital Specialty Finance a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Bain Capital Specialty Finance wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Bain Capital Specialty Finance saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 225,300 shares, an increase of 57.3% from the June 15th total of 143,200 shares. Based on an average daily trading volume, of 162,900 shares, the days-to-cover ratio is currently 1.4 days. Approximately 0.4% of the shares of the stock are sold short.
View Bain Capital Specialty Finance's Short Interest.

Bain Capital Specialty Finance is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Bain Capital Specialty Finance.

Bain Capital Specialty Finance will be holding an earnings conference call on Thursday, August 5th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "8880299 #".

Bain Capital Specialty Finance, Inc. (NYSE:BCSF) announced its quarterly earnings data on Tuesday, May, 4th. The company reported $0.34 EPS for the quarter, hitting the Zacks' consensus estimate of $0.34. The firm earned $49.83 million during the quarter. Bain Capital Specialty Finance had a net margin of 74.93% and a trailing twelve-month return on equity of 8.11%.
View Bain Capital Specialty Finance's earnings history.

Bain Capital Specialty Finance's stock was trading at $16.84 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BCSF shares have decreased by 9.3% and is now trading at $15.28.
View which stocks have been most impacted by COVID-19.

Bain Capital Specialty Finance announced a quarterly dividend on Wednesday, May 5th. Stockholders of record on Wednesday, June 30th will be paid a dividend of $0.34 per share on Friday, July 30th. This represents a $1.36 annualized dividend and a yield of 8.90%. The ex-dividend date is Tuesday, June 29th.
View Bain Capital Specialty Finance's dividend history.

Bain Capital Specialty Finance pays an annual dividend of $1.36 per share and currently has a dividend yield of 8.86%. BCSF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Bain Capital Specialty Finance does not yet have a strong track record of dividend growth. The dividend payout ratio of Bain Capital Specialty Finance is 93.15%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Bain Capital Specialty Finance will have a dividend payout ratio of 99.27% in the coming year. This indicates that Bain Capital Specialty Finance may not be able to sustain their current dividend.
View Bain Capital Specialty Finance's dividend history.

2 brokers have issued 12-month target prices for Bain Capital Specialty Finance's shares. Their forecasts range from $14.00 to $15.50. On average, they expect Bain Capital Specialty Finance's share price to reach $14.75 in the next year. This suggests that the stock has a possible downside of 3.5%.
View analysts' price targets for Bain Capital Specialty Finance or view top-rated stocks among Wall Street analysts.

Some companies that are related to Bain Capital Specialty Finance include The Lion Electric (LEV), Ube Industries (UBEOY), Austerlitz Acquisition Co. II (ASZ), Janus International Group (JBI), Churchill Capital Corp VII (CVII), Paya (PAYA), Social Capital Hedosophia Holdings Corp. VI (IPOF), Ares Acquisition (AAC), Alight (ALIT), Foley Trasimene Acquisition (WPF), Reinvent Technology Partners Y (RTPY), indie Semiconductor (INDI), FTAC Hera Acquisition (HERA), Compute Health Acquisition (CPUH) and Cohn Robbins (CRHC).
View all of BCSF's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bain Capital Specialty Finance investors own include Verizon Communications (VZ), AbbVie (ABBV), The Walt Disney (DIS), Square (SQ), AT&T (T), Bristol-Myers Squibb (BMY), The Home Depot (HD), Advanced Micro Devices (AMD), Bank of America (BAC) and Energy Transfer (ET).

(BCSF) raised $156 million in an IPO on Thursday, November 15th 2018. The company issued 7,500,000 shares at a price of $20.25-$21.25 per share. BofA Merrill Lynch, Goldman Sachs, Morgan Stanley, Citigroup, Credit Suisse, Keefe, Bruyette & Woods (A Stifel Company) and Wells Fargo Securities served as the underwriters for the IPO and Janney Montgomery Scott, JMP Securities and Academy Securities were co-managers.

Bain Capital Specialty Finance trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCSF."

Bain Capital Specialty Finance's stock is owned by a variety of retail and institutional investors. Top institutional investors include Starr International Co. Inc. (1.22%) and C.V. Starr & Co. Inc. Trust (0.67%). Company insiders that own Bain Capital Specialty Finance stock include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle, Sally F Dornaus and Thomas A Hough.
View institutional ownership trends for Bain Capital Specialty Finance.

BCSF stock was bought by a variety of institutional investors in the last quarter, including C.V. Starr & Co. Inc. Trust, and Starr International Co. Inc.. Company insiders that have bought Bain Capital Specialty Finance stock in the last two years include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle, Sally F Dornaus, and Thomas A Hough.
View insider buying and selling activity for Bain Capital Specialty Finance or or view top insider-buying stocks.

Shares of BCSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BCSF stock can currently be purchased for approximately $15.28.

Bain Capital Specialty Finance has a market capitalization of $986.51 million and generates $194.46 million in revenue each year. The company earns $8.28 million in net income (profit) each year or $1.46 on an earnings per share basis.

The official website for Bain Capital Specialty Finance is www.baincapital.com.

Bain Capital Specialty Finance is headquartered at 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116.

Bain Capital Specialty Finance's mailing address is 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at 617-516-2000 or via email at [email protected]